Department of Psychiatry and Behavioural Neurosciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Psychiatry Clin Neurosci. 2023 Nov;77(11):583-591. doi: 10.1111/pcn.13582. Epub 2023 Sep 11.
To determine whether the coronavirus disease 2019 (COVID-19) pandemic was associated with a change in psychiatric symptoms in people with preexisting obsessive-compulsive, eating, anxiety, and mood disorders compared to their prepandemic levels.
We searched MEDLINE, CINAHL, PsycINFO, and Embase from inception until February 16, 2022. Studies were included if they reported prepandemic and during-pandemic psychiatric symptoms, using validated scales, in people with preexisting mood, anxiety, eating, or obsessive-compulsive disorders. Two reviewers independently screened studies, extracted data, and assessed evidence certainty. Random-effects meta-analyses were conducted. Effect sizes were reported as standardized mean differences (SMDs) with 95% confidence intervals (CIs).
Eighteen studies from 10 countries were included. Of the 4465 included participants, 68% were female and the average age was 43 years. Mood and obsessive-compulsive disorders were the most studied disorders. During-pandemic psychiatric measurements were usually collected during nationwide lockdown. Obsessive-compulsive symptoms worsened among people with obsessive-compulsive and related disorders, with a moderate effect size (N = 474 [six studies], SMD = -0.45 [95% CI, -0.82 to -0.08], I = 83%; very low certainty). We found a small association between the COVID-19 pandemic and reduced anxiety symptoms in people with mood, anxiety, obsessive-compulsive, and eating disorders (N = 3738 [six studies], SMD = 0.11 [95% CI, 0.02-0.19], I = 63%; very low certainty). No change in loneliness, depressive, or problematic eating symptoms was found.
People with obsessive-compulsive and related disorders may benefit from additional monitoring during the COVID-19 pandemic and possibly future pandemics. Other psychiatric symptoms were stable in people with the specific disorders studied. Overall, evidence certainty was very low.
确定与大流行前水平相比,患有预先存在的强迫症、进食障碍、焦虑症和心境障碍的人在新冠疫情期间是否出现了精神病症状的变化。
我们检索了 MEDLINE、CINAHL、PsycINFO 和 Embase 自成立以来至 2022 年 2 月 16 日的数据。如果研究报告了预先存在的心境、焦虑、进食或强迫症患者在大流行期间使用经过验证的量表评估的精神病症状,则纳入研究。两位评审员独立筛选研究、提取数据并评估证据确定性。进行了随机效应荟萃分析。效应大小以标准化均数差(SMD)及其 95%置信区间(CI)表示。
纳入了来自 10 个国家的 18 项研究。在纳入的 4465 名参与者中,68%为女性,平均年龄为 43 岁。心境和强迫症是研究最多的疾病。大流行期间的精神病学测量通常是在全国封锁期间收集的。强迫症及相关障碍患者的强迫症症状恶化,具有中度效应大小(N=474 [6 项研究],SMD=-0.45 [95%CI,-0.82 至 -0.08],I²=83%;极低确定性)。我们发现新冠疫情与心境、焦虑症、强迫症和进食障碍患者的焦虑症状减轻之间存在小关联(N=3738 [6 项研究],SMD=0.11 [95%CI,0.02-0.19],I²=63%;极低确定性)。未发现孤独、抑郁或进食障碍症状的变化。
在新冠疫情期间,强迫症及相关障碍患者可能需要额外的监测,可能在未来的大流行中也是如此。在研究的特定疾病患者中,其他精神病症状保持稳定。总体而言,证据确定性极低。